Lucia Martin-Rodriguez

Lucia Martin-Rodriguez

Auto-generated profile, based on publicly available information

Lucia Martin-Rodriguez

Molecular Neuropathology Unit, Physiological and Pathological Processes Program, Centro de Biología Molecular Severo Ochoa, CSIC-UAM, 28049, Madrid, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JRJose Ruiz-Iglesias
Jose Ruiz-Iglesias
EBElena R. Bovolenta
Elena R. Bovolenta
LCLucía Cañizares-Moscato
Lucía Cañizares-Moscato
JIJavier Isoler-Alcaraz
Javier Isoler-Alcaraz
LMLucía Martín-Rodriguez
Lucía Martín-Rodriguez
EPErnest Palomer
Ernest Palomer
The epigenetic landscape of individual cells determines their identity and function, yet current methods for profiling chromatin modifications at single-cell resolution remain low-throughput, costly, or limited in parametric depth. Here we present EpiFlow, a spectral flow cytometry-based platform that enables the simultaneous quantification of 16 epigenetic markers, including histone post-translational modifications, DNA methylation, and hydroxymethylation, at the single-cell level. We demonstrate that EpiFlow is robust across species from yeast to mammals and resolves biologically meaningful epigenetic transitions during the cell cycle, stem cell differentiation, germinal centre B cell maturation, diabetic liver remodelling, and seizure-induced chromatin reprogramming. High-dimensional integration of EpiFlow data enables cell-type classification based solely on epigenetic profiles in liver, brain, blood, and cancer. Furthermore, EpiFlow detects on-target and off-target/indirect effects of epigenetic drugs in a high-throughput-compatible format. Collectively, these results establish EpiFlow as a broadly applicable platform for single-cell epigenetic analysis in basic, pharmaceutical, and translational research.

7 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ERElisa Cintado Reyes
Elisa Cintado Reyes
PMPablo Muela
Pablo Muela
LMLucia Martin-Rodriguez
Lucia Martin-Rodriguez
IAIgnacio Alcaide
Ignacio Alcaide
PTPatricia Tezanos
Patricia Tezanos
JTJosé Luis Trejo
José Luis Trejo
Lifestyle factors, particularly physical exercise, significantly influence brain structure and cognitive function through a hormetic effect dependent on exercise intensity and duration. The underlying mechanisms of this profile remain largely unexplored. Recently, the gut microbiota, has emerged a potent modulator of lifestyle-induced changes on brain and behavior. Here, we demonstrate that a 40-minute protocol of moderate exercise enhances cognitive abilities related to object recognition and memory, and increases hippocampal neurogenesis in adult mice compared to sedentary controls, but these cognitive and neurogenic benefits vanish when the exercise intensity or duration is increased. Furthermore, we identified significant alpha- and beta-diversity changes and distinct bacteria composition profiles of gut microbiota associated with different exercise regimens. Specific bacterial families showed altered relative abundances depending on exercise intensity and duration, with certain families’ quantities significantly correlating with cognitive performance ( Angelakisella, Acetatifactor, Erysipelatoclostridium , and Coriobacteriaceae UCG-002.). To parse causal mechanisms, fecal microbiota transplantation from exercised to sedentary mice replicated the cognitive and brain structural improvements observed in the donor animals. These findings suggest that the hormetic effects of physical exercise on cognitive function and neurogenesis are mediated by corresponding changes in the gut microbiota, indicating a novel mechanistic link between exercise, brain, and gut microbiota composition.